Full Length Research Paper
References
|
Aggarwal N, Goindi S, Khurana R (2013). Formulation, characterization and evaluation of an optimized microemulsion formulation of griseofulvin for topical application. Colloids and Surfaces B. Biointerfaces 105:158-166. |
|
|
Alberti I, Kalia YN, Naik A, Bonny JD, Guy RH (2001). In vivo assessment of enhanced topical delivery of terbinafine to human stratum corneum. J. Controlled Release 71(3):319-327. |
|
|
Benfeldt E, Hansen SH, Vølund A, Menné T, Shah VP (2007). Bioequivalence of topical formulations in humans: evaluation by dermal microdialysis sampling and the dermatopharmacokinetic method. J. Invest. Dermatol. 127(1):170-8. |
|
|
Brasil, Guia para validação de métodos analíticos. Diretoria colegiada da Agência Nacional de Vigilância Sanitária, Resolução No899, 2003. |
|
|
Brasil, Lista A de medicamentos de referência, 2015, presentation slides available at |
|
|
Chik Z, Tucker AT, Shiel JI (2010). Comparative Pharmacokinetic Assessments of Topical Drugs: Evaluation by Dermatopharmacokinetics, Microdialysis, and Systemic Measurement. J. INVEST. DERMATOL. 130(12): 2828-2830. |
|
|
FDA Guidance for industry on special protocol assessment (2002). Fed. Regist. 67:35122. |
|
|
Hathout RM, Mansour S, Geneidi AS, Mortada ND (2011). Visualization, dermatopharmacokinetic analysis and monitoring the conformational effects of a microemulsion formulation in the skin stratum corneum. J. colloid interface sci. 354(1):124-130. |
|
|
Herkenne C, Naik A, Kalia YN, Hadgraft J, Guy RH (2007). Ibuprofen transport into and through skin from topical formulations: in vitro–in vivo comparison. J. Invest. Dermatol. 127(1):135-142. |
|
|
Herkenne C, Naik A, Kalia YN, Hadgraft J, Guy RH (2006). Dermatopharmacokinetic prediction of topical drug bioavailability in vivo; Pharm. Res. 8(4): 887-894. |
|
|
Lodén M, Åkerström U, Lindahl K, Berne B (2004). Bioequivalence determination of topical ketoprofen using a dermatopharmacokinetic approach and excised skin penetration. Int. J. pharm. 284(1):23-30. |
|
|
Patel NA, Patel NJ, Patel RP (2009). Drug Discov. Ther. 3(5):234-242. |
|
|
N'Dri-Stempfer B, Navidi WC, Guy RH, Bunge AL (2008). Optimizing metrics for the assessment of bioequivalence between topical drug products. Pharm. Res. 25(7):1621-1630. |
|
|
Nagelreiter C, Mahrhauser D, Wiatschka K, Skipiol S, Valenta C (2015). Int. J. Pharm.491:162-169. |
|
|
Pershing LK, Bakhtian SC, Poncelet J, Corlett EL, Shah VP (2002). J. Pharm. Sci. 91:5. |
|
|
Pershing LK, Corlett J, Jorgensen C (1994). In vivo pharmacokinetics and pharmacodynamics of topical ketoconazole and miconazole in human stratum corneum. Antimicrob. agents chemother.38(1):90-95. |
|
|
Dai W, Wang C, Yu C, Yao J, Sun F, Teng L, Li Y (2015). Preparation of a mixed-matrix hydrogel of vorinostat for topical administration on the rats as experimental model. Eur J. Pharm. Sci. 78:255-263. |
|
|
Wan T, Xu T, Pan J, Qin M, Pan W, Zhang G, Xu Y (2015). Microemulsion based gel for topical dermal delivery of pseudolaric acid B: In vitro and in vivo evaluation. Int. J. Pharm. 493(1):111-120. |
|
|
Wiedersberg S, Dermatopharmacokinetics and pharmacodynamics of topical glucocorticoids. Thesis submitted for a degree of Doctor of Philosophy, University of Bath, Department of Pharmacy and Pharmacology. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
